Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
GSK-3 inhibitor elraglusib enhances tumor-infiltrating im... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer
0
Authors
Kelsey Huntington
15 more
Kelsey Huntington
•
Lanlan Zhou
13 more
•
Wafik El‐Deiry
Published
February 7, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Medicine
Immunology
Cancer Research
Show all topics
DOI
10.1101/2023.02.07.527499
License
CC-BY-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Medicine
Immunology
Cancer Research
Show all topics
DOI
10.1101/2023.02.07.527499
License
CC-BY-ND
Other Formats
PDF
